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Activity of hepatic metabolic enzymes of glucuronidation and sulfation of 4-nitrophenol (PNP) and 
biliary excretion of its glucuronide (PNP-G) and sulfate (PNP-S) conjugates have been investigated in 
control and streptozotocin (STZ)-induced diabetic rats. 500 μM PNP solution was luminally perfused in 
a cannulated jejunal loop for 90 minutes. It was found that biliary excretion of PNP-G was significantly 
decreased in the diabetic rats. This effect of STZ could be completely reversed by administration of rapid-
acting insulin. Activity of hepatic UDP-glucuronyltransferase and β-glucuronidase was also depressed 
by the STZ pretreatment. Administration of insulin antagonized the inhibitory action of STZ on UDP-
glucuronyltransferase, but the reduced activity of β-glucuronidase was not reversed. Biliary excretion 
of PNP-S was also depressed in the diabetic rats. Whereas, different effects of insulin administration 
were observed. Namely, the lower biliary excretion rate of PNP-S was not changed after administration 
of insulin. Activity of the sulfotransferase and the arylsulfatase enzymes was not altered either by STZ 
pretreatment or by insulin administration. Biliary excretion of PNP was also significantly depressed 
by STZ and this depression was not changed after insulin administration. The results call attention to 
hepatobiliary circulation of low molecular weight xenobiotics and their glucuronide and sulfate conjugates.
Keywords: 4-Nitrophenol. Hepatic excretion. Glucuronide conjugate. Sulfate conjugate. Experimental 
diabetes.
INTRODUCTION
Orally administered drugs, before they reach the 
systemic blood circulation, can be metabolized in the 
intestinal tract and the liver. Biotransformation of drugs 
before entering the systemic circulation is referred to as 
first pass metabolism. Numerous (Phase I. and Phase II.) 
reactions are involved in biotransformation of xenobiotics 
in the liver and small intestine (Linn, Chiba, Baillie, 
1999; Parkinson et al., 2013). Phenolic compounds are 
generally metabolized by Phase II reactions. In the present 
experiments 4-nitrophenol (PNP) was used as a model 
substance, because it is known to be metabolized almost 
exclusively by glucuronidation and sulfation (Kuhn, 
Rost, Müller, 2001) producing 4-nitrophenol-glucuronide 
(PNP-G) and 4-nitrophenol-sulfate (PNP-S). These 
reactions are catalyzed by UDP- glucuronyltransferases 
(Tukey, Strassburg, 2000; Parkinson et al., 2013) and 
sulfotransferases (Capiello et al., 1989; Maiti et al., 2004; 
Parkinson et al., 2013) in the liver and the small intestine. 
Esterases (β-glucuronidase and arylsulfatase) play also 
an important role in biotransformation of drugs, because 
these enzymes can hydrolyze the glucuronide and the 
sulfate conjugates (Danovitch, Laster, 1969; Parkinson 
et al., 2013). 
Several factors, e.g. drug interactions, nutrient 
deficiencies, pathological alterations, diseases including 
diabetes can influence metabolism of drugs (Liu et al., 
2012; Tormo et al., 1995; Watkins, Dykstra, 1987). 
Experimental diabetes is generally produced by i.v. 
administration of streptozotocin (STZ) in a dose of 65 mg/
kg in rats, which causes a destruction of pancreatic β-cells. 
Diabetes can provoke several effects on carbohydrate and 
lipid metabolism, intermediary processes as well as on 
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drug metabolism and hepatic and intestinal transport of 
drugs, (Fischer, Lauterbach, 1984; Tomkin, Owens, 2015). 
Little definitive data are available, however, concerning 
the effects of diabetes on the excretory function of the liver, 
the metabolic enzyme activities and the role of insulin in 
these processes and alterations.
In our previous experiments effect of diabetes on the 
excretory function of the small intestine and the activities 
of the related enzymes were investigated (Fischer et al., 
2015). The results indicated that experimental diabetes 
increased intestinal glucuronidation of PNP but did not 
influence sulfate conjugation.
The present experiments were designed to study 
the effects of STZ-induced experimental diabetes on the 
hepatic elimination of PNP during its luminal perfusion in 
a jejunal loop of rats. For this purpose, biliary excretion of 
PNP-G and PNP-S as well as activities of hepatic UDP-
glucuronyltransferase, β-glucuronidase, sulfotransferase 
and arylsulfatase enzymes were determined to get 
information about the relationship between the biliary 
excretion rates and the respective enzyme activities. The 
prompt effect of the insulin was also studied on biliary 
excretion of the PNP metabolites and the enzyme activities 
in the diabetic rats.
MATERIAL AND METHODS
Chemicals
4-nitrophenol (PNP), 4-nitrophenol-ß-glucuronide 
(PNP-G), 4-nitrophenol-sulfate (PNP-S), 4-ethylphenol 
(ETP), streptozotocin (STZ), tetrabutyl ammonium 
bromide (TBAB), phenolphthalein-ß-glucuronide, 
uridine 5’-diphosphoglucuronic acid (UDPGA), 
3’-phosphoadenosine-5-phosphosulphate (PAPS), 
nitrocatechol (NC)-sulfate, 4-naftol, Brij56®, HEPES, 
DL-dithiothreithol were obtained from Sigma Aldrich 
Company (Budapest, Hungary). All other chemicals and 
reagents were analytical or HPLC grade. The standard 
isotonic perfusion medium had the following composition 
(mmol/l): NaCl 96.4, KCl 7.0, CaCl2 3.0, MgSO4 1.0, 
sodium phosphate buffer (pH 7.4) 0.9, TRIS buffer (pH 
7.4) 29.5, glucose 14.0, mannitol 14.0.
Animals and experimental procedure
Male Wistar rats (weighing 220-250 g) were 
randomly separated into three groups of seven rats each. 
In group I and II experimental diabetes was induced 
by i.v. administration of STZ (65 mg/kg bw). Control 
animals (group III) were treated with saline. Experimental 
procedure was performed after one week of the STZ-
treatment. Rats of group II were treated with rapid-acting 
insulin (Actrapid) (1 IU/kg bw, i.v.) just before the 
anesthesia. Liver and bile samples were obtained from 
the same rats of the three different groups of rats (control, 
STZ-pretreated with or without insulin).
The animals were anesthetized with urethane (1.2 
g/kg bw, i.p.). The abdomen was opened by a mid-line 
incision and a jejunal loop (length about 10 cm) was 
isolated and cannulated in vivo. Body temperature was 
maintained at 37 °C with a heat lamp. The lumen of the 
jejunal loop was gently flushed with warmed isotonic 
solution to remove digesta and food residues and then 
blown empty with 4-5 mL of air. Perfusion through the 
lumen of the jejunal loop with isotonic medium containing 
500 µM PNP was carried out at a rate of 13 ml/min in a 
recirculation mode for 90 minutes. The initial volume 
was 15 mL. The temperature of perfusion medium was 
maintained constant at 37 °C. Bile was collected in 15 
minute-periods into tared Eppendorf tubes placed in ice. 
The collected samples were stored in refrigerator (-20 oC) 
until analysis. Bile flow was measured gravimetrically 
assuming a specific gravity of 1.0. Biliary excretion was 
calculated as the product of the concentration in bile and 
bile flow.
Analytical conditions, instrumentation
Bile samples were analyzed by a UV-Vis RP-HPLC 
method, as it was developed and published earlier (Almási 
et al., 2011). Briefly, 50 µL of bile samples was mixed 
and vortexed with cold methanol in a total volume of 
containing 2.5 mM ETP as internal standard. A mixture 
of 0.01 M citrate buffer (pH 6.2) and methanol (47:53 
v/v%) containing 0.03 M tetrabutyl ammonium bromide 
was used as a mobile phase. The flow rate of the mobile 
phase was 1.0 mL.min-1. 
The HPLC system consisted of a Varian 2010 pump, 
a Rheodyne 7724i injection valve and a UV-Detector 308 
(Labor MIM, Budapest, Hungary). Data were recorded 
and evaluated by a PowerChrom 280 data module and 
software (ADInstruments, Sydney, Australia). Separation 
of compounds was performed on a Nucleosyl 100 C18 
reversed phase analytical column (250 mm x 4.6 mm 
I.D., 10 µm particle size) with a TR-C-160K1 ODS guard 
column. UV measurements were performed on a Pye 
Unicam (Philips) PU 8800 UV-Vis spectrophotometer 
(Philips, Cambridge, UK) at ambient temperature. 
Injection volume was 20 μL.
A Mettler Toledo MP 220 pH meter and a Mettler 
Toledo Inlab 413 electrode (Mettler Toledo, Budapest, 
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Hungary) were used to adjust the pH of the electrolyte 
solutions.
Enzyme assays
UDP-glucuronyltransferase and ß-glucuronidase assays
UDP-glucuronytransferase assay
Liver obtained from control (isotonic medium) and 
perfused (500 μM PNP) rats were gently dissected and 
immediately frozen and stored at – 80 °C temperature. 
250 – 500 mg liver samples were dissected and placed 
into 2.5-5 mL of cold (4 °C) homogenization buffer (250 
mM sucrose, 1 mM DL-dithiothreithol, 10 mM Hepes-Tris 
buffer pH 8.0) and disrupted using an Ultra-Turrax and 
Potter-Elvehjem homogenizers.
After disruption, the homogenate was diluted with 
the homogenization buffer to have a protein concentration 
of 1 mg/ml. Quantification of protein was performed in 
each enzyme assay by the biuret method (van Norman, 
1909).
UGT enzyme activity assays were carried out in an 
incubation mixture of 100 μL of liver homogenate (1 mg/
ml protein) and 100 μL of incubation buffer (200 mM Tris-
HCl, 10 mM MgCl2, 0.1 % Brij56® pH 7.4) containing 2 
mM PNP. Half of the incubates contained 5 mM UDPGA 
in the total volume. After 30 min incubation at 37 °C, the 
reaction was quenched by adding 3.8 ml of 0.1 M ice cold 
NaOH and the absorbance of the unconjugated PNP was 
measured at 405 nm. Specific UGT activity was calculated 
on the base of metabolized PNP and expressed in μmol 
PNP/mg/min (Capiello, Giuliani, Pacifici, 1991).
β-Glucuronidase assay
Dissection, storage and homogenization of liver 
samples were the same as described for the UDP-
glucuronyltransferase assay. ß-Glucuronidase activity 
assays were carried out in an incubation mixture of 100 
μL of liver homogenate (1 mg/mL protein) and 150 μL 
of 70 mM pH 5.0 acetate buffer. Half of the incubates 
contained 1 mM phenolphthalein-β-glucuronide in 
the total volume. After 60 min incubation at 37 °C the 
reaction was quenched by adding 250 μL of ice cold 
5% trichloroacetic acid. Samples were neutralized 
by adding 0.22 M glycine solution of pH 12.9. The 
absorbance was measured at 540 nm. β-Glucuronidase 
activity was calculated on the base of the metabolized 
phenolphthalein and it is expressed in the amount of the 
formed free phenolphthalein: µmol/mg/min. The mixture 
of the acetate buffer, the glycine solution and distilled 
water was used as a reference (Fishman, 1974).
Sulfotransferase and arylsulfatase assays
· Sulfotransferase assay 
Dissection, storage and homogenization of liver 
samples were the same as described for the UDP-
glucuronyltransferase assay. Liver was quickly dissected 
and immediately frozen and stored at -80 °C until 
analysis. Homogenization was performed in cold (4 °C) 
homogenization buffer (250 mM sucrose, 1 mM DL-
dithiothreithol, 10 mM Hepes-Tris buffer pH 8.0).
Determination of sulfotransferase activity was 
carried out with incubation of 100 μL of liver homogenate 
and 400 μl of incubation buffer (62.5 mM Tris buffer, pH 
6.2) containing 25 μM PAPS, 125 μM 2-naftol, and 6.25 
mM 4-nitrophenol sulfate. The reaction was started by 
addition of the homogenate to the incubation buffer.
After 30 min incubation at 37 °C the reaction was 
quenched by adding 500 μL of 0.25 M Tris buffer, pH 8.7. 
Absorption of the formed 4-nitrophenol was measured at 
401 nm. Reference solution contained homogenization 
buffer without organ homogenate (Maiti et al., 2004). 
The advantage of this assay is that the sulfotransferases 
also catalyze the sulfuryl group transfer from PNP-S to 
regenerate PAP-S and the forming PNP can be easily 
detected by UV-Vis spectrophotometry.
· Arylsulfatase assay
Dissection, storage and homogenization of liver 
samples were the same as described for the UDP-
glucuronyltransferase assay.
Determination of arylsulfatase activity was carried 
out with incubation of 50 μL of liver homogenate and 
400 μL of incubation buffer (in a concentration of 0.25 
M sodium-acetate buffer pH 5.5) containing 0.01 M 
nitrocatechol sulfate. The reaction was started by adding 
the homogenate to the incubation buffer. After 30 min 
incubation at 37 °C the reaction was quenched by adding 
500 uL of 5 m/v% trichloroacetic acid. Thereafter the 
mixture was centrifuged at 1600 x g for 10 minutes. 
Then 500 μL of supernatant was added to 500 μL of 5 M 
NaOH solution and absorption of the formed nitrocatechol 
was measured at 520 nm. Reference solution contained 
homogenization buffer instead of the homogenate 
(Danovitch, Laster, 1969).
Calculations, statistical analysis
Enzyme activities are expressed in the amounts of 
substrates or metabolites (µmol glucuronide and nmol 
sulfate) calculated for 1 mg protein and 1 minute (details 
in “Enzyme assays” and “Results”).
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The biliary excretion rate of PNP and the metabolites 
were calculated on the base of their concentration in the 
bile and the volume of the biliary flow. Data show the mean 
± S.E. of seven experiments.
Data were analyzed by one-way ANOVA, the 
difference among groups was determined by post hoc 
Tukey test and (p<0.05) was significant.
Ethical approval
All procedures were carried out on animals according 
to the Hungarian Animal Protection Act (Hungarian Act 
XXVIII, 1998). The study was approved by the Ethics 
Committee on Animal Research of the University of Pécs.
RESULTS
The blood glucose level of the experimental animals 
was 8.61 ± 1.59 mmol/L in the control, 27.1 ± 4.04 mmol/L 
in the diabetic, and 9.49 ± 3.88 mmol/L in the diabetic rats 
with insulin treatment.
The bile flow was determined for each 15 minute-
period. The obtained data are summarized in Table I. As 
it shown STZ treatment statistically did not change the 
bile flow rate. On the contrary, insulin treatment resulted 
in statistically significant increase of the bile flow rate 
in comparison to both the STZ-nontreated and the STZ-
treated groups.
Figure 1 shows the cumulative biliary excretion 
(sum of the excreted amounts in 90 minutes) of PNP-G 
at the luminal perfusion of 500 μM PNP. Significantly 
lower amount of PNP-G was excreted into the bile in 
diabetic rats than in the controls. Depression of biliary 
excretion of PNP-G was compensated by rapid-acting 
insulin administration.
Figure 2 and Figure 3 summarize activities of the 
enzymes which play important role in synthesis (UDP-
glucuronyltransferase) and hydrolysis (β-glucuronidase) 
of PNP-G in the liver. As Figure 2 shows, activity of UDP-
glucuronyltransferase was significantly decreased in the 
diabetic rats. The depression was antagonized by insulin 
administration. The results show parallelism with alterations 
of biliary excretion of PNP-G in the respective groups.
Similarly to UDP-glucuronyltransferase, a decreased 
activity of β-glucuronidase was observed in the diabetic 
rats (Figure 3). This decrease, however, was less 
pronounced than that measured for the corresponding 
transferase. The depressed activity was not reversed by 
insulin administration.
TABLE I - The 15-minute period bile flows (µL/kg/min) in the various experimental groups
Time period 
(min) 500 µM PNP
500 µM 
PNP+STZ
500 µM 
PNP+STZ+Insulin
0 – 15 63.1 ± 4.4 54.8 ± 8.7 81.6 ± 7.5#
15 – 30 60.5 ± 3.7 54.8 ± 6.6 103.1 ± 7.8**,##
30 – 45 60.6 ± 4.2 49.6 ± 5.7 96.7 ± 12.7*,##
45 – 60 58.7 ± 4.1 58.6 ± 7.8 96.1 ± 4.0**,##
60 – 75 59.6 ± 3.5 52.7 ± 6.1 93.3 ± 6.2**,##
75 – 90 57.4 ± 3.2 47.1 ± 6.9 90.2 ± 8.1**,##
The 15-minute period bile flows (µL/kg/min) over the 90-min luminal perfusion of 500 µM PNP in control (PNP) and diabetic rats 
without (PNP+STZ) or with insulin (PNP+STZ+Insulin) administration. Data represent the mean of ± S.E. of seven rats. Significant 
difference from the control value: ** p<0.01, * p<0.05. Significant difference from the value of STZ-diabetic rats without insulin 
administration: ## p< 0.01, # p < 0.05.
FIGURE 1 - Cumulative biliary excretion of PNP-G after the 
90-min luminal perfusion of 500 µM PNP in control and diabetic 
rats without or with insulin administration. Data represent the 
mean of ± S.E. of seven rats. Significant difference from the 
control value: ** p<0.01. Significant difference from the value 
of STZ-diabetic rats without insulin administration: ## p<0.01.
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The cumulative biliary excretion of PNP-S is shown 
in Figure 4. STZ-pretreatment significantly decreased 
biliary excretion of PNP-S in comparison to the control 
values. These results indicate that alteration in the biliary 
excretion of PNP-S shows the same tendency observed 
for PNP-G. Insulin administration, however, could not 
reverse the depressed biliary excretion rate of PNP-S in the 
diabetic rats. No significant difference was found between 
the values of the STZ-pretreated rats with or without 
insulin administration.
Sulfotransferase activity of the liver was not 
changed either by STZ or insulin treatment (Figure 5). No 
significant difference was observed between the values of 
the control and the diabetic rats without or with insulin 
treatment.
Figure 6 illustrates hepatic activity of arylsulfatase. 
No significant difference was observed between the values 
of control and STZ-pretreated rats without or with insulin. 
These finding shows similarity to that of the corresponding 
change of sulfotransferase activity. 
Data of Figure 7 shows that experimental diabetes 
produced by STZ significantly decreased biliary excretion 
of the unconjugated PNP. It can also be seen that insulin 
was unable to antagonize the decreasing effect of STZ 
pretreatment on the biliary excretion rate of PNP.
DISCUSSION
The effect of STZ-induced experimental diabetes 
FIGURE 2 - Activity of UDP-glucuronyltransferase of the 
liver in control and diabetic rats without or with insulin 
administration. Values represent the mean ± S.E. of seven 
rats. Significant difference from the control value: ** p<0.01. 
Significant difference from the value of STZ-diabetic rats 
without insulin administration: ## p<0.01. The enzyme activity 
is expressed in μmol PNP/mg/min, which was conjugated in 1 
minute calculated for 1 mg protein of the liver.
FIGURE 3 - Activity of β-glucuronidase of the liver in control 
and diabetic rats without or with insulin administration. Values 
represent the mean ± S.E. of seven rats. Significant difference 
from the control value: ** p<0.01. Significant difference from 
the value of STZ-diabetic rats without insulin administration: 
## p<0.01. The columns show the amount of phenolphthalein 
formed from its glucuronide in 1 minute calculated for 1 mg 
liver protein.
FIGURE 4 - Cumulative biliary excretion of PNP-S after the 90-
min luminal perfusion of 500 µM PNP in control and diabetic 
rats without or with insulin administration. Data represent the 
mean of ± S.E. of seven rats. Significant difference from the 
control value: ** p<0.01. No significant difference was found 
between the values of STZ-diabetic rats without or with insulin 
administration.
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has been investigated on biliary excretion of PNP and 
its conjugated metabolites (PNP-G, PNP-S) as well as 
on activity of the respective metabolic enzymes, while 
PNP was luminally perfused in the jejunal loop of 
anesthetized rats. The pathological state induced by STZ 
administration, due to its specific B-cell cytotoxicity, is 
considered to closely resemble that of insulin-dependent 
diabetes mellitus (Agarwal, 1980). STZ-doses of 50-65 
mg/kg bw lead to hyperglycemia (20-30 mmol/L) but 
severe ketosis does not develop even if insulin is not 
administered (Wei et al, 2003). Such a treatment is also 
useful as a model of phrenic nerve neuropathy in the rats 
(Rodrigues Filho, Fazan, 2006). The experiments were 
performed 1 week after the STZ treatment. By that time the 
expected hyperglycemia (27 mmol/L) has been developed.
Earlier results showed that bile flow rate in STZ-
treated rats is a function of time after administration of 
STZ: bile flow is diminished immediately for several days 
after STZ injection, whereas the flow is normal one month 
after STZ (Stone et al., 1997; Boyer, 2013). This might 
be the reason why some authors have reported decreased 
(Andrews, Griffiths, 1984; Carnovale, Rodriguez-Garay, 
1984) whereas others have reported normal bile flow 
or even choleresis (Watkins, Dyktsra, 1987; Watkins, 
Sherman, 1992). In long term diabetes, however, several 
other factors - change in steady state volume of distribution 
and in some pharmacokinetic parameters (transport 
proteins, bile duct contractility) - may also influence 
hepatic disposition of xenobiotics (Tormo et al., 1995; Liu 
et al., 2010; Zhang et al., 2011). In the present experiments 
bile flow rate was not affected by the 7-day STZ-treatment 
(Table I). The bile flow rate values are in accord with the 
expected normal choleretic values (Boyer, 2013).
It was found that STZ treatment depressed biliary 
excretion of PNP-G, which could be compensated by 
short-acting insulin administered prior to the experiment 
(Figure 1). Activity of both liver UDP-glucuronyltransferase 
and β-glucuronidase was also lower in the diabetic rats than 
those in the controls (Figures 2 and 3). Insulin antagonized 
the depression of UDP-glucuronyltransferase, whereas the 
decreased activity of β-glucuronidase was not influenced 
by administration of rapid-acting insulin.
FIGURE 5 - Activity of sulfotransferase of the liver in control 
and diabetic rats without or with insulin administration. Values 
represent the mean ± S.E. of seven rats. The sulfotransferase 
activity is expressed in nmol PNP-S, which was produced in 1 
minute calculated for 1 mg liver protein. 
FIGURE 6 - Activity of arylsulfatase of the liver in control and 
diabetic rats without or with insulin administration. Values 
represent the mean ± S.E. of seven rats. Data expressed in nmol 
of 4-nitrocatechol (4-NC), which was produced from 4-NC 
sulfate in 1 minute calculated for 1 mg liver protein.
FIGURE 7 - Cumulative biliary excretion of PNP after the 90-
min luminal perfusion of 500 µM PNP in control and diabetic 
rats without or with insulin administration. Data represent the 
mean of ± S.E. of seven rats. Significant difference from the 
control value: ** p<0.01. No significant differences were found 
between the values of STZ-diabetic rats without or with insulin 
administration.
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There have been several studies demonstrating 
that conjugation reactions, including conjugation of 
PNP, are sensitive to the level of carbohydrate reserves 
and cofactor supply (Reinke et al., 1979; Thurman et 
al., 1981; Qu, Kauffman, Thurman, 1995). Increased 
production of UDP-GA can augment the capacity of liver 
to form glucuronide even without a detectable increase 
of glucuronyltransferase activity (Miettinen, Leskinen, 
1970). The background of the increased production of 
UDP-GA is that the flux of glucose in tissues of diabetic 
rats is shunted to insulin insensitive pathways when flow 
through insulin-sensitive routes is inhibited (Watkins, 
Dyktsra, 1987). 
Diabetes is known to be a major disorder in which 
oxidative stress and free radical production have been 
implicated through several lines of evidence (Hinokio 
et al., 1999; Suzuki et al., 1999; Brownlee, 2001) In the 
liver, involvement of reactive oxygen radicals has been 
suggested in apoptotic cell death of hepatocytes and 
endothelial cells (Jaeschke, 2000). It was demonstrating 
that insulin treatment impairs the increase of hydroxyl 
radical (.OH) production generated by the STZ-induced 
diabetic state in the rat liver (Frances et al., 2010). 
According to these earlier observations, the enhanced 
glucuronide excretion caused by insulin administration is 
supposed to be the consequence of relief of the oxidative 
stress resulting in increased availability of UDP-GA and 
regenerated enzyme activity.
Biliary excretion of PNP-S was decreased in diabetic 
rats similarly to that of PNP-G, whereas, insulin was 
unable to compensate the depressed biliary excretion of 
PNP-S (Figures 4-6). No change was found, however, 
either in sulfotransferase or in arylsulfatase activities in 
diabetic rats regardless they were treated with insulin or 
not. Sulfate conjugation in hepatocytes of insulin-treated 
diabetic rats was also found to be less intense than that of in 
the control rats (Eacho, Sweeny, Weiner, 1981). Decrease 
in sulfation of PNP and in biliary excretion of PNP-S can 
be explained by depletion of ATP, because it is required 
in synthesis of PAPS. Hyperglycemia induced oxidative 
stress depletes ATP, which is subsequently utilized for 
synthesis of PAPS, the cofactor required for sulfation. 
Similar mechanism is considered for reduced availability 
of UDP-GA (Li et al., 2015).
STZ-induced diabetes significantly decreased 
biliary excretion of the unconjugated PNP (Figure 
7). Administration of insulin doesn’t antagonize the 
decreasing effect. In intact rats anions with molecular 
weight lower than 350 mainly excreted by the kidney 
(Lehman-McKeeman, 2013). Our experiment shows that 
some PNP can be excreted into the bile, which – in intact 
rats - can be reabsorbed from the small intestine. These 
experimental findings call attention to hepatobiliary 
circulation of law molecular weight xenobiotics as well 
as their sulfate and glucuronide conjugates. Further 
mechanistic studies are needed to identify the molecular 
mechanism of hyperglycemia-induced decrease of the 
three (PNP, PNP-G and PNP-S) ionizable compounds 
into the bile.
Comparison the above results with those obtained 
in our previous work shows different patterns of change 
in enzyme activities and the amount of the respective 
metabolites. Thus, the STZ-initiated diabetes raised the 
luminal appearance of PNP-G and the increase could 
be completely reversed by rapid-acting insulin. The 
changes were in parallel with alterations in the respective 
enzyme activities (Fischer et al., 2015). The differences 
can be explained by the different effects determining the 
amount of the excreted metabolites in the two organs. 
Whereas, glucuronidation in the small intestine is directly 
related to the actual blood glucose level, in the hepatic 
processes direct action of insulin has also to be taken into 
considerations. Insulin has been reported to increase the 
bile flow and biliary excretion of drugs in experimental 
animals (Garberoglio et al., 1983; Thomsen, Larsen, 1982). 
Neither the luminal appearances of PNP-S nor the related 
intestinal enzyme activities, however, were significantly 
influenced by the experimental hyperglycemia (Fischer 
et al., 2015). 
CONCLUSION
T h e s e  e x p e r i m e n t s  s h o w  i m p o r t a n c e  o f 
hyperglycemia in hepatic excretion of PNP as well as its 
glucuronic acid and sulfate conjugates in the rats. The 
changes in the biliary excretion can be partly explained by 
the altered activities of the metabolic enzymes involved 
in synthesis of the two conjugates. No direct correlation 
was found between alterations of the enzyme activities 
and appearance of the respective metabolites in the bile. 
Accordingly, other factors (e.g. transport processes, 
availability of cofactors, bile acid production) should also 
be important in the effects of experimental diabetes on 
hepatic elimination of drugs.
ACKNOWLEDGEMENT
The present scientific contribution is dedicated to the 
650th anniversary of the foundation of the University of 
Pécs, Hungary. This study was supported by the University 
of Pécs, Faculty of Medicine Research Fund (AOK-
KA-34039/10/01 and AOK-KA-2013/20). The authors 
A. Almási, E. I. L. N. Pinto, N.-P. Kovács, T. Fischer, Z. Markovics, E. Fischer, P. Perjési
Braz. J. Pharm. Sci. 2018;54(1):e17347Page 8 / 9
express their special thanks to Reiszné Horváth Mária for 
her excellent technical assistance. 
REFERENCES
Almási A, Fischer E, Perjési P. Isocratic ion-pair HPLC method 
for quantitation of 4-nitrophenol and it’s conjugated metabolites 
from bile. Sci Pharm. 2011;79(4):837-847.
Agarwal MK. Streptozotocin: mechanisms of action. FEBS 
Lett. 1980;120(1):1-3.
Andrews SM, Griffiths LA. The metabolism and disposition of 
[2-14C]diazepam in the streptozotocin-diabetic rat. Xenobiotica. 
1984;14(10):751-760.
Boyer JL. Bile formation and secretion. Compr Physiol. 
2013;3(3):1035-1078.
Brownlee M. Biochemistry and molecular cell biology of 
diabetic complications. Nature. 2001;414(6865):813-820.
Capiello M, Franchi M, Giuliani L, Pacifici GM. Distribution 
of 2-naphthol sulfotransferase and its substrate adenosine 
3-phosphate 5-phosphosulfate in human tissues. Eur J Clin 
Pharmacol. 1989;37(3):317-320.
Capiello M, Giuliani L, Pacifici GM. Distribution of UDP-
glucuronyltransferase and its endogenous substrate uridine 
5-diphosphoglucuronic acid in human tissues. Eur J Pharmacol. 
1991;41(4):345-350.
Carnovale CE, Rodriguez-Garay EA. Reversible impairment 
of hepatobiliary function induced by streptozotocin in the rat. 
Experientia 1984;40(3):248-250.
Danovitch SH, Laster R. The development of arylsulfatase in 
the small intestine of the rat. Biochem J. 1969;114(2):343-350.
Eacho PI, Sweeny D, Weiner M. Conjugation of p-nitroanisole 
and p-nitrophenol in hepatocytes isolated from streptozotocin 
diabetic rats. J Pharmacol Exp Ther. 1981;218(1):34-40.
Fischer E, Almási A, Bojcsev S, Fischer T, Kovács NP, Perjési 
P. Effect of experimental diabetes and insulin replacement on 
intestinal metabolism and excretion of 4-nitrophenol in rats. Can 
J Physiol Pharmacol. 2015;93(6):459-464.
Fischer E, Lauterbach F. Effect of hyperglycaemia on sugar 
transport in the isolated mucosa of guinea-pig small intestine. J 
Physiol. 1984;355:367-386.
Fishman WH. β-Glucuronidase. In: Bergmeyer HU (Ed). 
Methods of Enzymatic Analysis New York: Academic Press; 
1974; p. 929-943.
Frances DE, Ronco MT, Monti JA, Ingaramo PI, Pisani GB, 
Parody JP, Pellegrino JM, Sanz PM, Carrillo MC, Carnovale 
CE. Hyperglycemia induces apoptosis in rat liver through the 
increase of hydroxyl radical: new insights into the insulin effect. 
J Endocrinol. 2010;205(2):187-200.
Garberoglio CA, Richter HM3rd, Henarejos A, Moossa 
AR, Baker AL. Pharmacological and physiological doses of 
insulin and determinants of bile flow in dogs. Am J Physiol. 
1983;245(1):G157-173.
Hinokio Y, Suzuki S, Hirai M, Chiba M, Hirai A, Toyota T. 
Oxidative DNA damage in diabetes mellitus: its association with 
diabetic complications. Diabetol. 1999;42(8):995-998.
Hungarian Act 1998 XXVIII on Protection and Careful 
Treatment of Animals.
Jaeschke H. Reactive oxygen and mechanisms of inflammatory 
liver injury. J Gastroenterol Hepatol. 2000;15(7):718-724.
Kuhn MD, Rost M, Müller D. Para-nitrophenol glucuronidation 
and sulphatation in rat and human slices. Exp Toxic Pathol. 
2001;53(1):81-87.
Li S, Tan H-Y, Wang N, Zhang Z-J, Lao L, Wong C-W, Feng Y. 
The role of oxidative stress and antioxidants in liver diseases. 
Int J Mol Sci. 2015;16(11):26087-26124.
Linn LH, Chiba M, Baillie TA. Is the role of the small intestine 
in first–pass metabolism overemphasized? Pharm Rev. 
1999;51(2):135-151.
Liu C, Su H, Wang Y, Tung T, Chou P, Chou Y, Liu J, Chen 
J. Reduced bile duct contractile function in rats with chronic 
hyperglycemia. Health. 2010;2(9):1072-1077.
Liu H, Wu B, Pan G, He I, Li Z, Fan M, Jian L, Chen M, Wang 
K, Huang C. Metabolism and pharmacokinetics of mangiferin 
in conventional rats, pseudo-germ free rats, and streptozotocin-
induced diabetic rats. Drug Metab Dispos. 2012;40(11):2109-
2118.
Lehman-McKeeman LD. Absorption, distribution and excretion 
of toxicants. In: Casarett and Doull’s toxicology: the basic 
science of poisons. 8th Ed. (Klaassen CD, Ed.). New York: 
McGraw-Hill Education; 2013; Chap. 5; p. 153-184.
Changes in hepatic metabolic enzyme activities and biliary excretion of 4-nitrophenol in streptozotocin induced diabetic rats
Braz. J. Pharm. Sci. 2018;54(1):e17347 Page 9 / 9
Maiti S, Grant S, Baker SM, Karanth S, Pope CN, Chen G. 
Stress regulation of sulfotransferases in male rat liver. Biochem 
Biophys Res Commun. 2004;323(1):235-241.
Miettinen TA, Leskinen E. Glucuronic acid pathway. In: 
Fishman WH (Ed.) Metabolic conjugation and metabolic 
hydrolysis. New York: Academic Press; 1970; p.157-238.
Parkinson A, Ogilvie BW; Buckley DB, Kazmi F, Czerwinski 
M, Parkinson O. Biotransformation of Xenobiotics. In: Casarett 
and Doull’s toxicology: the basic science of poisons, 8th Ed. 
(Klaassen CD, Ed.). New York: McGraw-Hill Education; 2013; 
Chap. 6; p. 185-366.
Qu W, Kauffman FC, Thurman RG. Food restriction stimulates 
conjugation of p-nitrophenol ion perfused rat liver. Arch 
Biochem Biophys. 1995; 319(2):451-456.
Reinke LA, Kauffman FC, Evans RK, Belinsky SA and Thurman 
RG. p-Nitrophenol conjugation in perfused livers from normal 
and phenobarbital-treated rats: Influence of nutritional state. 
Res Commun Chem Pathol Pharmacol. 1979;23(1):185-193.
Rodrigues Filho OA, Fazan VPS. Streptozotocin induced 
diabetes as a model of phrenic nerve neuropathy in rats. J 
Neurosci Meth. 2006;151(2):131-138.
Stone JL, Braunstein JB, Beaty TM, Sanders RA, Watkins JB 
III. Hepatobiliary excretion of bile acids and rose bengal in 
streptozotocin-induced and genetic diabetic rats. J Pharmacol 
Exp Ther. 1997;281(1):412-419.
Suzuki S, Hinokio Y, Komatu K, Ohtomo M, Onoda M, 
Hirai S, Hirai M, Hirai A, Chiba M, Kasuga S, Akai H, 
Toyota T. Oxidative damage to mitochondrial DNA and its 
relationship to diabetic complications. Diabetes Res Clin Pract. 
1999;45(2-3):161-168.
Thomsen OO, Larsen JA. Interaction of insulin, glucagon, and 
DBcAMP on bile acid-independent bile production in the rat. 
Scand J Gastroenterol. 1982;17(5):687-693.
Thurman RG, Reinke LA, Belinsky S, Evans RK, Kauffman FC. 
Co-regulation of the mixed-function oxidation of nitroanisole 
and glucuronidation of p-nitrophenol in the perfused rat 
liver by carbohydrate reserves. Arch Biochem Biophys. 
1981;209(1):137-142.
Tomkin GH, Owens D. Dyslipidaemia of diabetes and the 
intestine. World J Diabetes. 2015;6(7):970-977.
Tormo MA, Gómez-Zubeldia MA, Roppero F, Muñoz-Casillas 
M, Moreno JC, Campillo JE. Experimental streptozotocin-
reduced diabetes and intestinal glucose metabolism in the rat, 
in vivo and in vitro. Acta Diabetol. 1995;32(3):182-186.
Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: 
metabolism, expression and disease. Ann Rev Pharmacol 
Toxicol. 2000;40:581-616.
Van Norman KH. The biuret reaction and the cold nitric acid test 
in the recognition of protein. Biochem J. 1909;4(3-4):127-35.
Watkins JBIII, Dykstra TP. Alterations in biliary excretory 
function by streptozotocin-induced diabetes. Drug Metab 
Dispos. 1987;15(2):177-183.
Watkins JBIII, Sherman SE. Long-term diabetes alters the 
hepatobiliary clearance of acetaminophen, bilirubin and digoxin. 
J Pharmacol Exp Ther. 1992;260(3):1337-1343.
Wei M, Ong L, Smith MT, Ross FB, Schmid K, Hoey AJ, 
Burstow D, Brown L. The streptozotocin-diabetic rat as a model 
of the chronic complications of human diabetes. Heart Lung 
Circulation. 2003;12(1):44-50.
Zhang L, Liang L, Jin S, Jing X, Yao D, Hu N, Liu L, Duan R, 
Liu X, Wang G, Xie L. Tissue specific alterations in expression 
and function of P-gp in STZ induced diabetic rats. Acta 
Pharmacol Sin. 2011;32(7):956-966.
Received for publication on 11th June 2017
Accepted for publication on 23th September 2017
This is an open-access article distributed under the terms of the Creative Commons Attribution License.
